A new method for the therapeutic drug monitoring of chlorpromazine in plasma by gas chromatography–mass spectrometry using dispersive liquid–liquid microextraction

The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, stock ownership or options and expert testimony.

Comments (0)

No login
gif